These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 16152824)
1. [Clinical study on ginkgolide nebulised inhalation in treating bronchial asthma]. Ni J; Dong JC Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):696-9. PubMed ID: 16152824 [TBL] [Abstract][Full Text] [Related]
2. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma]. Weng JL; Zheng YS; Ma QF Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388 [TBL] [Abstract][Full Text] [Related]
3. [Experimental study on prevention and treatment of bronchial asthma by compound Chinese herbal monomer recipe]. Dong JC; Ni J; Gong ZH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Aug; 24(8):717-21. PubMed ID: 15366597 [TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil cationic protein and bronchial hyperresponsiveness to hypoosmolar challenge in naive atopic asthmatics. Dal Negro R; Tognella S; Micheletto C; Pomari C; Burti E; Mauroner L; Turco P J Investig Allergol Clin Immunol; 1998; 8(5):294-9. PubMed ID: 9827426 [TBL] [Abstract][Full Text] [Related]
5. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics. Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma. Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782 [TBL] [Abstract][Full Text] [Related]
7. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601 [TBL] [Abstract][Full Text] [Related]
8. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Chetta A; Foresi A; Del Donno M; Consigli GF; Bertorelli G; Pesci A; Barbee RA; Olivieri D Am J Respir Crit Care Med; 1996 Mar; 153(3):910-7. PubMed ID: 8630572 [TBL] [Abstract][Full Text] [Related]
9. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels]. Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients. Terzano C; Guerra S; Allegra L Eur Rev Med Pharmacol Sci; 2001; 5(2):43-51. PubMed ID: 11863318 [TBL] [Abstract][Full Text] [Related]
11. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma]. Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020 [TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects. Siffredi M; Mastropasqua B; Pelucchi A; Chiesa M; Marazzini L; Foresi A Ann Allergy Asthma Immunol; 1997 Feb; 78(2):238-43. PubMed ID: 9048536 [TBL] [Abstract][Full Text] [Related]
13. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule. Kunkel G; Rydén AC Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995 [TBL] [Abstract][Full Text] [Related]
14. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation]. Ohbayashi H Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275 [TBL] [Abstract][Full Text] [Related]
16. Ciclesonide is more effective than budesonide in the treatment of persistent asthma. Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345 [TBL] [Abstract][Full Text] [Related]
17. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler. Möller M; Fritsche D; Rivera D; Libertus H Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246 [TBL] [Abstract][Full Text] [Related]
18. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087 [TBL] [Abstract][Full Text] [Related]
19. [Effect of dosing schedule on efficacy of corticosteroid inhalation in chronic asthma]. Suzuki R; Taki F; Taniguchi H; Kondoh Y; Tanaka H; Watanabe Y; Suzuki K; Ogawa K; Torii K; Takagi K Arerugi; 1995 Jul; 44(7):685-91. PubMed ID: 7575134 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]